These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24326971)

  • 1. Aminoglycosides for life-threatening infections: a plea for an individualized approach using intensive therapeutic drug monitoring.
    De Waele JJ; De Neve N
    Minerva Anestesiol; 2014 Oct; 80(10):1135-42. PubMed ID: 24326971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Level of evidence for therapeutic drug monitoring of aminoglycosides].
    Venisse N; Boulamery A;
    Therapie; 2011; 66(1):39-44. PubMed ID: 21466776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring.
    Croes S; Koop AH; van Gils SA; Neef C
    Eur J Pharm Sci; 2012 Jan; 45(1-2):90-100. PubMed ID: 22094306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing dosing of antibiotics in critically ill patients.
    Parker SL; Sime FB; Roberts JA
    Curr Opin Infect Dis; 2015 Dec; 28(6):497-504. PubMed ID: 26382000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological considerations for the proper clinical use of aminoglycosides.
    Pagkalis S; Mantadakis E; Mavros MN; Ammari C; Falagas ME
    Drugs; 2011 Dec; 71(17):2277-94. PubMed ID: 22085385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoglycoside drugs in clinical practice: an evidence-based approach.
    Leibovici L; Vidal L; Paul M
    J Antimicrob Chemother; 2009 Feb; 63(2):246-51. PubMed ID: 19022778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing use of aminoglycosides in the critically ill.
    Rea RS; Capitano B
    Semin Respir Crit Care Med; 2007 Dec; 28(6):596-603. PubMed ID: 18095223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients.
    Mueller EW; Boucher BA
    Surg Infect (Larchmt); 2009 Dec; 10(6):563-70. PubMed ID: 20035611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoglycosides use in patients over 75 years old.
    Fraisse T; Gras Aygon C; Paccalin M; Vitrat V; De Wazieres B; Baudoux V; Lechiche C; Vicens A; Sotto A; Pagani L; Gaillat J; Forestier E; Gavazzi G
    Age Ageing; 2014 Sep; 43(5):676-81. PubMed ID: 24590569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost-effectiveness analysis of active TDM in elderly patients treated with aminoglycosides].
    Leon-Djian CB; Bourguignon L; Späth HM; Maire P
    Therapie; 2011; 66(5):445-52. PubMed ID: 22031689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases.
    Hainrichson M; Nudelman I; Baasov T
    Org Biomol Chem; 2008 Jan; 6(2):227-39. PubMed ID: 18174989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative pharmacology: a focus on aminoglycosides.
    Bruce K; Hicks RW
    AORN J; 2011 Apr; 93(4):464-8; quiz 469-71. PubMed ID: 21459184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do we still need the aminoglycosides?
    Durante-Mangoni E; Grammatikos A; Utili R; Falagas ME
    Int J Antimicrob Agents; 2009 Mar; 33(3):201-5. PubMed ID: 18976888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycosides in the intensive care unit: an old drug in a dynamic environment.
    Miyagawa CI
    New Horiz; 1993 May; 1(2):172-80. PubMed ID: 7922400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum level monitoring of aminoglycoside antibiotics. Limitations in intensive care unit-related bacterial pneumonia.
    Flint LM; Gott J; Short L; Richardson JD; Polk HC
    Arch Surg; 1985 Jan; 120(1):99-103. PubMed ID: 3966875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aminoglycosides in pediatrics].
    Truckenbrodt H
    Adv Clin Pharmacol; 1978; 15():141-8. PubMed ID: 676873
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring of a single post-infusion blood sample to estimate the actual peak and trough concentration of tobramycin in critically ill patients.
    Reimann IR; Meier-Hellmann A; Traut T; Reinhart K; Hoffmann A
    Exp Toxicol Pathol; 2003 Jun; 54(5-6):493-8. PubMed ID: 12877363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycoside therapy in infectious diseases.
    Poulikakos P; Falagas ME
    Expert Opin Pharmacother; 2013 Aug; 14(12):1585-97. PubMed ID: 23746121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?
    Wong G; Sime FB; Lipman J; Roberts JA
    BMC Infect Dis; 2014 Nov; 14():288. PubMed ID: 25430961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity.
    Avent ML; Rogers BA; Cheng AC; Paterson DL
    Intern Med J; 2011 Jun; 41(6):441-9. PubMed ID: 21309997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.